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BACKGROUND AND OBJECTIVE: 
In hyperacute ischaemic stroke, T2 of cerebral water increases with time. Quantifying this 
change may be informative of the extent of tissue damage and onset time. Our objective was 
to develop a user-unbiased method to measure the effect of cerebral ischaemia on T2 to study 
stroke onset time-dependency in human acute stroke lesions. 
METHODS: 
Six rats were subjected to permanent middle cerebral occlusion to induce focal ischaemia, 
and a consecutive cohort of acute stroke patients (n = 38) were recruited within 9 hours from 
symptom onset. T1-weighted structural, T2 relaxometry, and diffusion MRI for apparent 
diffusion coefficient (ADC) were acquired. Ischaemic lesions were defined as regions of 
lowered ADC. The median T2 difference (T2) between lesion and contralateral non-
ischaemic control region was determined by the newly-developed spherical reference method, 
and data compared to that obtained by the mirror reference method. Linear regressions and 
receiver operating characteristics (ROC) were compared between the two methods. 
RESULTS: 
T2 increases linearly in rat brain ischaemia by 1.9 ± 0.8 ms/h during the first 6 hours, as 
determined by the spherical reference method. In patients, T2 linearly increases by 1.6 ± 1.4 
and 1.9 ± 0.9 ms/h in the lesion, as determined by the mirror reference and spherical reference 
method, respectively. ROC analyses produced areas under the curve of 0.83 and 0.71 for the 
spherical and mirror reference methods, respectively.  
CONCLUSIONS: 
Data from the spherical reference method showed that the median T2 increase in the 
ischaemic lesion is correlated with stroke onset time in a rat as well as in a human patient 
cohort, opening the possibility of using the approach as a timing tool in clinics. 
Keywords: T2 relaxation time, diffusion MRI, stroke onset time, acute ischaemic stroke 
 
Running head: Stroke onset time dependent T2 relaxation time change in ADC lesion 
  
 1. Introduction 
The mainstay of hyperacute ischaemic stroke treatment is reperfusion therapy, including 
intravenous thrombolysis and mechanical intra-arterial thrombectomy. Both treatments are 
effective at reducing disability but only if initiated sufficiently soon after the onset of ischaemia 
[20]. As time elapses the likelihood of benefit from treatment declines and the risk of 
haemorrhagic complications of treatment increases. At present thrombolysis using 
recombinant tissue plasminogen activator (rtPA) is licensed up to 4.5 hours after onset of 
symptoms and is therefore rarely used when the time of symptom onset is unknown such as 
when symptoms become apparent on waking (often termed “wake-up stroke”). Mechanical 
thrombectomy using stent-retrievers is a more recent and highly effective treatment for 
ischaemic stroke caused by occlusion of a major intra-cerebral vessel. Again, the benefit of 
treatment declines with duration of ischaemia; some current guidelines recommend that 
treatment should commence within 6 hours of symptom onset. 
A recently evaluated approach using MRI compares hyperintense signal on diffusion weighted 
imaging (DWI) with T2 FLAIR [24]: a bright DWI signal that is not apparent on FLAIR has 
reasonable specificity for onset within the preceding 4.5 hours, and visual assessment of this 
“DWI-FLAIR mismatch” formed the basis for patient selection in the WAKE-UP clinical trial, 
which demonstrated significant improvement in outcome when such patients were treated with 
intravenous rtPA [26]. The subjective nature of MRI interpretation using this approach may, 
however, limit uptake. An alternative is to make use of quantitative T2 mapping, which seeks 
to parameterise the T2 in an image of its values [27]. The change in T2 underpins the FLAIR 
signal intensity changes. Animal models using rats [7, 16], cats and primates, as well as 
theoretical models [13] have demonstrated that the T2 relaxation time increases in ischaemic 
tissue roughly linearly at ~1 – 2 ms/hour (after an initial drop) for the first few hours after onset 
consistently across species [9]. There is evidence for a similar rate of increase in humans [21]. 
However, measurement of the change of T2 from a baseline (unmeasured, pre-ischaemic) 
state becomes very difficult in the brains of higher species, for there is considerable anatomical 
variation in T2, which varies by more than the change caused by ischaemia. For example, the 
average T2 in the corticospinal tracts is about 10 – 15 ms higher than in other white matter 
structures [12], a larger difference than the anticipated T2 change during the first 6 hours of 
ischaemia. 
The purpose of this study is to demonstrate the viability of a new user-independent method of 
estimating images of the pre-ischaemic brain based on images of the ischaemic brain, and 
therefore preparing images of the change caused by ischaemia. The approach prepares 
images of the change in any “imageable” quantity. We demonstrate that, in particular, images 
of the pre-ischaemic ADC and T2 relaxation time may be calculated and thereby the change 
caused by ischaemia to be determined. We validate our method in a rat model of cerebral 
ischaemia and apply it in a cohort of human acute ischaemic stroke patients. We obtain 
estimates of the probable T2 and ADC change with time across the entire ADC-demarcated 
lesions, revealing heterogeneity of T2 change. We propose that the median T2 change is a 
good reporter of lesion age, for it correlates well with stroke onset time. 
  
2. Methods 
2.1. Animal data acquisition and processing 
Male Wistar rats (n=6, weight 200 – 300 g) were exposed to permanent middle cerebral artery 
occlusion (MCAo) [15] and scanned by a procedure described in [16]. The occluding thread 
was left in place for the duration of the MRI scanning and the animal was sacrificed thereafter 
by decapitation in deep isoflurane anaesthesia. Animal procedures were conducted according 
to European Community Council Directives 86/609/EEC guidelines and approved by the 
Animal Care and Use Committee of the University of Eastern Finland.  
A horizontal 9.4 T Agilent MRI scanner (Agilent, Palo Alto, CA, US) equipped with an actively 
decoupled linear volume transmitter and quadrature receiver coil pair (RAPID Biomedical 
GmbH, Rimpar, Germany) was used. Each measurement comprised a 3-plane diffusion-
weighted sequence (b-values = 0, 400, 1040 s/mm2; TE = 36 ms, TR = 2000 ms) and a multi-
echo spin-echo sequence (12 echoes 10 ms inter-echo spacing, TR = 2000 ms). Twelve slices 
were imaged with the following parameters: 0.5 mm gap, slice thickness = 1 mm, FOV = 2.56 
cm x 2.56 cm was covered by 128 x 256 points. Measurements, each taking ~20 minutes, 
were made at times commencing 60, 120, 180 and 240 minutes after MCAo. 
 
2.2. Human data acquisition and processing 
The study received ethical approval to accrue acute stroke patients from South West Frenchay 
Research Ethics Committee for participants in Bristol (reference 13/SW/0256), Scotland A 
REC for participants in Glasgow (reference 16/SS/0223), and UK National Research Ethics 
Service Committee for participants in Oxford (references 12/SC/0292 and 13/SC/0362). 
Informed consent was received either from participants or their legal representative prior to 
enrolment to the study. Stroke patients were recruited if they presented in the emergency 
department with witnessed symptom onset so that MRI scans could be completed with 9 hours 
of onset. Details of the human acute stroke cohort is given in Table 1. The project was carried 
out in accordance with the Declaration of Helsinki.  
 
All MRI scans on stroke patients were acquired using 3T scanners: Philips Achieva (Bristol); 
Siemens Magnetom Prisma (Glasgow); Siemens Magnetom Verio (Oxford). At each of the 
three sites, a 32-channel head-coil was used. The details of the T1, diffusion, and T2 pulse 
sequences and acquisition parameters are given in Table 2. 
 
Quantitative T2 maps were obtained by fitting a mono-exponential decay on a voxel-wise 
basis. All echoes of the TE series were summed to produce a sum-over-echoes image, which 
was subject to bias field correction [29] using FSL FAST (FMRIB, Oxford, UK).  
For diffusion-weighted data with a single b-value, apparent diffusion coefficient (ADC) maps 
were calculated using 
 ( )0lnADC S S b= −   
where S and S0 are the signal intensities with and without diffusion weighting respectively and 
b is the b-value. For data using three orthogonal diffusion-sensitising gradients at a common 
b-value, ADC maps were obtained from  
𝐴𝐷𝐶 = − ln(𝑆1𝑆2𝑆3 𝑆0
3⁄ ) 3𝑏⁄  
where S1,2,3 are the signal intensities at the 3 orthogonal directions, S0 as before, b as before. 
Diffusion-weighted data (Glasgow) with twenty independent diffusion-gradient directions 
(b=1000 mm2/s) and three b=0 images were processed using FSL DTIFIT from which the 
mean-diffusivity maps provided the ADC values. 
  
2.3 Lesion identification and mask creation 
Brain-extracted images were analysed following rigid-body co-registration to the MNI frame at 
1 mm isotropic resolution resampling using FSL FLIRT [6]. The ADC maps were first co-
registered to T2-weighted space by a non-linear registration of the S0 image to the sum-over-
echoes image using FSL FNIRT. In this co-registered space, the ADC lesion was demarcated 
as follows. 
A reference tissue mask was first created by the application of thresholds on T2 and ADC to 
reduce the contribution from CSF. These thresholds were typically 30 ms <  T2 < 200 ms, 0.1 
µm2 ms-1 < ADC < 1.5 µm2 ms-1. A lesion tissue mask was then created in two stages. First, 
the thresholds (which could vary in individual cases) 30 ms <  T2 < 200 ms, 0.2 – 0.4 µm2 ms-
1 < ADC < 0.55 – 0.60 µm2 ms-1 were applied and, secondly, the additional criterion—that the 
ADC should be less than one half-width half-maximum from the median ADC of the reference 
tissue—was applied. The lesion mask was then further refined by removing all but the largest 
contiguous cluster (or clusters, in the cases of more than one lesion). This lesion mask was 
then removed from the reference tissue mask to create a non-lesion tissue mask.   
2.4 Algorithm for T2 change due to ischaemia 
To calculate the change in T2 due to ischaemia for each voxel in the lesion, it is necessary to 
provide reference, T2R, values to which each voxel’s ischaemic T2 can be compared. That is, 
an estimate is needed for the pre-ischaemic T2 within each voxel of the lesion. Reference T2 
values have previously been obtained [7, 21] from single contralateral voxels in the unaffected 
hemisphere. However, such a method is prone to error due to the imperfect symmetry and 
heterogeneity of the human brain. To circumvent this issue, pre-ischaemic (reference) T2 
values are calculated from voxels within reference spheres of a given radius, centred on the 
contralateral voxel.  
To achieve this, the algorithm adopts the premise that, in the hyperacute phase of ischaemia, 
the T2-weighted images are relatively insensitive to ischaemia and therefore the intensity 
values within each voxel of the lesion are sufficiently close to their pre-ischaemic values to be 
taken as estimates for their pre-ischaemic values. With this premise, the intensity IL of a lesion 
voxel can be used to condition the reference T2 for that voxel. 
Despite the relative insensitivity to ischaemia of the T2-weighted intensities, there may still be 
a dependency between the intensities and T2 values in normal brain tissue within any given 
region. Therefore, it is possible to obtain an estimate of pre-ischaemic T2 by using the intensity 
estimate of the pre-ischaemic intensity (i.e., the ischaemic intensity value IL) to calculate a 
type of conditional expectation of T2 values within the reference sphere of a given lesion voxel. 
That is, an estimate of the pre-ischaemic T2 is obtained by the mean T2 of normal brain tissue 
within a reference sphere, conditioned by the intensity value IL of the ischaemic lesion voxel. 
To effect the conditioning, we employ a penalty function 𝐹(𝐼) which weights the sum over the 
T2 values associated with voxels indexed by k in a reference sphere S. Therefore, let the 
reference T2 be given by 
𝑇2
𝑅 = ∑ 𝑇2,𝑘𝐹(𝐼𝑘)
𝑁𝑆
𝑘=1
 
where NS is the number of voxels in the reference sphere S, and where the penalty function 
is normalised by ∑ 𝐹(𝐼𝑘)
𝑁𝑆
𝑘=1 = 1. This may be equivalently expressed as 
𝑇2
R =
〈𝑇2𝐹(𝐼)〉
〈𝐹(𝐼)〉
=
∫ d𝐼 𝐹(𝐼)𝑃(𝐼) ∫ d𝑇2 𝑇2𝑃(𝑇2|𝐼)
∫ d𝐼 𝐹(𝐼)𝑃(𝐼)
=
∫ d𝐼 𝐹(𝐼)𝑃(𝐼)⟨𝑇2|𝐼⟩
∫ d𝐼 𝐹(𝐼)𝑃(𝐼)
 
where the integrals are over the values contained in the reference sphere S, P(I) is the 
probability density for the intensities, P(T2|I) is the conditional probability density for T2 given 
the intensity I, and ⟨𝑇2|𝐼⟩ is the mean T2 conditioned on I. 
In the limit that F(I) is constant, T2R is the unweighted mean T2 of all the voxels in the reference 
sphere. Conversely, in the limit that F(I) becomes a delta-function positioned at IL, 𝑇2
R =
⟨𝑇2|𝐼
𝐿⟩. However, in the present context, the use of a delta-function is impractical. Instead, a 
penalty function of finite width is employed, such that 
𝐹(𝐼𝑘) = 𝐴
𝐿exp (− [
𝐼𝑘 − 𝐼
𝐿
𝐼𝐿
]
2
2𝜎2⁄ ) 
where AL is a normalisation constant which depends on each reference sphere associated 
with each lesion voxel. With this penalty function, T2R can be regarded as the mean T2 within 
the reference sphere, conditioned on a Gaussian neighbourhood of IL.  
With this method of obtaining the reference, T2R, for a given reference sphere associated with 
a lesion voxel and its T2-value, T2L, the estimated change is simply given by ∆𝑇2 = 𝑇2
𝐿 − 𝑇2
𝑅. 
This method can also be used to estimate changes in other MRI parameters, such as the ADC 
value.    
In our implementation of this algorithm, the T2-weighted intensities were obtained from the 
sum-over-echoes image after bias-field correction. The reference sphere radius and penalty 
function width, σ, were obtained by optimisation on each patient data set by using the 
unaffected tissue in the hemisphere of the lesion to minimise the function 𝑓(𝛽) = mad(∆𝑇2) +
 𝛽|median(∆𝑇2)|, with 𝛽 = 5, where ∆𝑇2 is the calculated change in  T2, and mad(∆𝑇2) is the 
median absolute deviation (MAD). The value of 𝛽 was chosen so that both summands had 
approximately equal weight. 
 
2.5. Mirror reference approach 
We used a method modified from that proposed by Siemonsen et al. [21] to determine a 
reference volume from the contralateral non-ischaemic hemisphere, but without the need for 
manual adjustments. Since all image processing was performed in the MNI frame, the midline 
of the brain is consistently defined. Therefore, the lesion mask (see section above) can simply 
be reflected about the midline and then logically combined with the non-lesion tissue mask to 
ensure that this contralateral (mirror reference) mask also contains only white and grey matter 
tissue. T2 statistics could then be easily compared between the lesion and the contralateral 
mask regions. 
2.6. Statistical Analysis 
All linear regressions were unweighted and performed within MATLAB (Release 2016b, The 
MathWorks, Inc., Natick, MA, US) using fit to obtain the fitting parameters, confidence intervals 
on the parameters, and the correlation coefficient, r2. Two-tailed t-tests on the null hypothesis 
for the gradient were conducted in the usual manner using the correlation coefficient and the 
degrees of freedom (df=33) to produce the quoted p-values. MATLAB’s predint was used to 
produce the observational 95% confidence intervals in the regression plots.  
Using SigmaPlot Version 13.0 (Systat Software, San Jose, CA, US), Receiver Operating 
Characteristic (ROC) curves were computed to determine the overall abilities of the spherical 
and mirror reference methods in distinguishing between patients scanned within () and 
beyond ()  4.5 hours from symptom onset.  Areas under the ROC curves (AUCs) were also 
calculated and statistically compared using the non-parametric approach for correlated ROCs 
[4]. 
  
3. Results 
3.1. Basics for the spherical reference method 
In Figure 1 we show examples of the spherical reference method using scans from an ADC-
negative patient. It is demonstrated that the spherical reference method is selective (Figure 
1c) for voxels which have similar T2-weighted intensity to the voxel of interest.  
 
3.2. Application to the rat MCAo 
Figure 2 shows example T2 and ADC maps for a rat during MCAo as well as the corresponding 
ΔT2 and ΔADC maps calculated using the voxel-wise parameter change algorithm. The 
lesions are visible in the ADC maps (and expand with time), and likewise visible as a negative 
ΔADC in the ΔADC images. This effectively validates the algorithm. In the corresponding ΔT2 
image, the ΔT2 in the vicinity of the lesion is generally positive, and more so at 4 hours than 
1 hour. Hemispheric images are shown since the non-lesion hemisphere is used to model the 
lesion hemisphere. 
Figure 3a provides an example of the shifting ΔT2 histogram with time in a MCAo rat, 
calculated with the voxel-wise algorithm. The right-shift at each time point is evident. It is also 
clear that there is a distribution of T2 changes across a lesion at any time point, so that not all 
voxels are equally affected by ischaemia. The width of a ΔT2 histogram, however, is 
determined not only by the heterogeneity of a lesion, but also by the error in the algorithm’s 
model for the pre-ischaemic state, and by imprecision of measurement of T2. The distributions 
cannot be less wide than the latter factor. Nonetheless, the width of a ΔT2 distribution provides 
an estimate of the heterogeneity of T2 change caused by ischaemia. This is a critical 
advantage of the spherical reference method over other T2 MRI approaches. 
Figure 3b shows the change in median ΔT2 with time for the 6 rats, using the MAD of their 
ΔT2 distributions as uncertainties. The rate of increase of median ΔT2 longitudinally is quite 
similar in the sampled time range. Cross-sectionally, however, there is variation. This variation 
appears to be determined by un-sampled early-time evolution and introduces considerable 
uncertainty into any cross-section estimate of onset time. From this sample, there is at least 5 
ms median ΔT2 variation four hours after occlusion. 
 
3.3. Application to human acute stroke 
Figure 4 shows the result of the spherical reference method applied to calculate ΔADC and 
ΔT2 images for a human acute ischaemic stroke patient. The lesion is visible as a low-ADC 
region in the diffusion image and is likewise visible as a negative ΔADC in the ΔADC image, 
thereby validating the algorithm in humans. In the corresponding ΔT2 image, the ΔT2 in the 
vicinity of the lesion is generally positive. Examples of ΔT2 distributions for a stroke lesion 
(Figure 4f) and the surrounding normal brain parenchyma (Figure 4e) are also shown. These 
demonstrate that the ΔT2 is centred very close to zero in brain regions in which there is no 
ischaemia or other neurological disease, whereas in the lesion a shift to right is evident. 
 
Figure 5 shows the cross-sectional relationships between reported onset time and parameters 
derived from the voxel-wise algorithm. Figure 5a demonstrates a positive correlation between 
stroke onset time and median ΔT2. We also see that the fit is not perfect, with the median ΔT2 
deviating from the fit by a cross-sectional variation larger than that seen in rats. The widths of 
ΔT2 distributions are also wider in humans, the median RMS errors from linear fits being 5.7 
ms, and 1.9 ms in rats. This may reflect greater heterogeneity of the lesion (ischaemia affects 
different voxels even more unequally in humans), the higher field strength used for the rat 
model, and/or greater uncertainty in the algorithm’s model for the pre-ischaemic state. 
Interestingly, the non-thrombolysed data points appear to fall almost to a flat line vs time of 
onset (Figure 5a). 
The linear model for the relationship between median ΔT2 and onset time in cross-sectional 
human data (1.9 ± 0.9 ms/h) is remarkably similar to that obtained in the rat cohort (1.92 ± 
0.78 ms/h) when analysed as a group (errors quoted are 95% confidence intervals), RMS error 
5.8 ms. Figure 5b shows a plot of the difference in median T2 between the lesion and its 
contralateral mirror region. A linear regression on this data gives a gradient of 1.6 ± 1.4 ms/h 
with an RMS error of 8.7 ms. Normalised T2-weighted intensity difference shows no time 
dependency, as the slope of the line against time of onset is not different from zero (Figure 
5c). 
 
Of the 38 patients, 25 were thrombolysed prior to MRI (Table 1) as part of standard of care. 
As rtPA may alter permeability of blood-brain-barrier, ADC was measured both in the stroke 
lesion and in the contralateral reference region. In the stroke lesions, the median ADC was 
found to be 0.51 ± 0.41 µm2 ms-1 and 0.55 ± 0.24 µm2 ms-1 for the thrombolysed and non-
thrombolysed patients, respectively. In the reference volumes, the corresponding median 
ADCs were 0.79 ± 0.41 µm2 ms-1 and 0.78 ± 0.60 µm2 ms-1. These values suggest that rtPA 
did not significantly affect the tissue state. 
 
ROC curves for the spherical and mirror reference approaches are displayed in Figure 6. Both 
AUCs were statistically significant, demonstrating good overall ability of both methods in 
distinguishing those patients that were scanned within 4.5 hours from symptom onset.  The 
spherical reference method had a higher AUC (AUC = 0.83, c.i. = 0.70 – 0.96, p < 0.001) than 
the mirror reference (AUC = 0.71, c.i. = 0.55 – 0.88, p = 0.016), the former AUC was 
significantly higher (p = 0.038) than the latter.  
 
4. Discussion 
 
We have developed a user-independent method for imaging changes in quantitative cerebral 
MRI parameters caused by stroke and applied it to determine the change in T2 relaxation time 
and ADC. We have shown that the method provides data from an animal model for acute 
stroke that are consistent with the mirror reference method [7] and translated the method to a 
cohort of human participants. A key development of the spherical reference method here is in 
generating an image or distribution of the change caused by stroke, accepting that not all 
voxels are equally affected by ischaemia. The previous mirror-reference approach has sought 
to deliver a “difference of averages”, with a single measurement value devoid of any measure 
of uncertainty or heterogeneity (but which is subject to both) [21]. Furthermore, any “difference 
of average” approach, such as comparison of the mean lesion T2 to mean contralateral T2, 
ignores the anatomical differences between the voxels sampled in lesion and contralateral 
reference mask. Our own simulations show that such uncertainty is considerable (data not 
shown). 
 
We compared the ability of the spherical reference approach with that of the modified mirror-
reference method where the non-ischaemic reference is determined by a reflection across the 
midline. The current way of determining the mirror-reference differs from the originally 
proposed [21] where the midline is visually inspected and corrected as needed to make 
selection of homologous region as good as possible whereas in the current approach no user 
input with midline is needed. Both methods reveal stroke onset time-dependent T2 in the 
ADC lesion with comparable ROC characteristics. The spherical reference approach produces 
less scattered T2 curves and also shows higher sensitivity at maximal specificity than the 
mirror-reference approach. The latter has an impact when treatment decisions for patients 
with unknown onset time are to be made to correctly exclude all patients that are beyond 4.5 
hours. There are two obvious reasons for improved performance of the spherical reference 
method. First, the new approach has superior ability to find the reference volume in non-
affected brain parenchyma avoiding CSF, thereby making the T2 distribution of the reference 
volume narrower and, second, the mirror-reference method is prone to misplacement due to 
inherent asymmetry of brain across the midline. Even a small misplacement will result in 
inaccurate T2 referencing [18]. Mirror-referencing in ageing brain may be problematic due to 
volumetric and tissue-related changes, such as white matter T2 hyperintensities.  
An angular dependence of T2 has been reported in human WM [11, 14]. The T2 anisotropy 
has been attributed primarily to result from diffusion-mediated decoherence due to anisotropic 
susceptibility gradients in WM, and at 3T it leads to variation in T2 up to approximately by 25 
ms. The T2 anisotropy is a potential confounding issue for the mirror reference methods, 
because it uses anatomy as a sole criterion for the contralateral non-ischaemic reference 
region. The spherical reference method instead should be less vulnerable to such anisotropy 
because of its voxel-wise intensity-matching algorithm (employing the penalty function).  
The time-based restrictions on both rtPA thrombolysis and mechanical thrombectomy mean 
that if the time of onset cannot be estimated, one or both treatment methods generally become 
unavailable. This affects a large number of potential recipients of treatment; for example, 
wake-up stroke occurs in 14 – 24% of cases [19, 22]. These patients are denied treatment, 
though they may have been within the treatment window. Both CT and MRI have been 
suggested to estimate whether a stroke has begun within a given time window. Using CT, a 
correlation between Hounsfield units in the core relative to a contralateral reference has been 
reported and converted into water uptake [17], reflecting vasogenic oedema. Such a 
correlation permits estimates of the time of onset, and is reported to have the potential to 
classify patients with strokes < 4.5 hr with sensitivity and specificity ranging from 79 – 91% 
and 52 – 85%, respectively. The CT protocol relies on cerebral blood flow data by perfusion 
CT to delineate the core, however.  
 
MRI using T2-weighted imaging has also been suggested as a method of estimating lesion 
age with the T2-FLAIR imaging (mainly T2-weighted, but with proton density- and T1-weighted 
contributions) [25]. This approach exploits a higher signal intensity arising from the lengthened 
T2 and increased proton density as the stroke progresses, as proxy of lesion age. However, 
this signal increase may be counteracted by a T1 contribution, which increases with time after 
onset in the first hours in animal models [9, 16], decreasing the FLAIR signal. A FLAIR lesion 
only becomes readily visible to the human eye after some time and the “DWI/FLAIR” mismatch 
has been suggested as a proxy of lesion age, which assigns a binary value of whether or not 
a FLAIR and DWI lesion can both be seen [24]. In a trial of 643 patients, it was shown that in 
the time range 181 – 270 minutes, 53% of patients show mismatch and 47% do not. The 
technique could classify those <4.5 hr with 62% sensitivity and 78% specificity, and for those 
<6 hr with 56% sensitivity and 87% specificity. The approach does, however, have the 
advantage that it suffers little if any confound from other factors [22, 23]. The binary 
classification using DWI/T2-FLAIR lesion mismatch [24, 28] has proven efficient to triage 
patients with unknown onset [26].  
 
An image of T2 relaxation time changes has several potential advantages over DWI/T2-FLAIR 
mismatch, however. First, the competition between contributions to T2-FLAIR intensity, mainly 
the T1-weighted part [16] which declines over time and therefore opposes the increase in T2 
over time, is not present in a quantitative T2 map. Second, an image of T2 change provides 
the possibility of quantifying how many voxels of the lesion (or beyond) change by a large 
amount [13, 16]. As such, whilst the average (we suggest median) ΔT2 may be a proxy of 
lesion age (with error of estimation as not all individuals exhibit the same kinetics), the 
heterogeneity of ΔT2 may provide some information on how many voxels have transitioned to 
a T2 reflective of infarction.  
 
A factor that has to be considered when using low-ADC delineation of stroke lesions is that 
the cerebral blood flow (CBF) thresholds for neurological symptoms and ischaemic energy 
failure (which triggers the drop in ADC) are different [5]. Animal studies have shown that 
neurological symptoms appear at CBF levels that are 50 – 60% below the physiological level 
[5], whereas energy failure and the associated ADC drop have a common flow threshold that 
is approximately 80% below the normal flow [2]. A further factor to be considered in this 
disparity is that these CBF thresholds are time-dependent, i.e. in a compromised 
haemodynamic state, ADC may drop at higher CBF with time than if the occlusion is 
instantaneous. In animal models the CBF drop to produce energy failure is controlled so that 
time of ischaemia is explicitly known. Thus, in rat MCAo we have determined the effect of 
ischaemia on T2, which may not be the case in human patients. In human strokes where 
time of ischaemia remains unknown, low ADC will not provide temporal information, rather just 
presence of ischaemia. In this scenario T2 data from ADC-delineated lesions in rat and 
human brain may well have different kinetics. In the ischaemic core in rats, T2 initially shortens 
relative to the non-ischaemic hemisphere lasting for an hour or so before the crossover a to 
positive gradient appears [3, 7]. The negative T2 results from combined effects of 
deoxyhaemoglobin build-up and shift of water from the extracellular to intracellular space [13]. 
In human ADC lesions the ΔT2 versus onset time curves closely resemble those from rats, 
with a crossover point around 2 hours from onset. A further factor to be considered is that 
stroke in rat brain is chiefly gray matter, whereas in humans both gray and white matter are 
affected, and the kinetics of T2 may differ between these tissue types. Despite all the 
potential confounds, our MRI data indicate that in the ischaemic core T2 increases 
approximately as much in rats (average 1.9 ms/h) as in humans (average 1.9 ms/h). It should 
be realised, however, that the percentage change in T2 is greater at 9.4T than at 3T due to 
shorter parenchymal T2 at ultrahigh field. 
4.1. From onset time to tissue characterisation 
It is known from animal research that tissue is more probable to become infarcted as its T2 
increases [8]. Therefore, an image of the extent to which T2 has increased may eventually be 
used as a proxy measure of what volume of ischaemic tissue is infarcted and what may still 
contain salvageable tissue [16]. This is likely to represent a fruitful future use of this 
methodology. The lesion age is often used as a proxy measure of this, and of the 
corresponding risk/benefit associated with reperfusion therapy. With additional research, it 
may be possible to move towards the use of the fraction of lesion tissue with a ΔT2 reflective 
of infarction and therefore potentially an improved estimate of infarct core. 
For now, onset time remains an important parameter for clinical decision making. Our results 
show that some inference regarding onset time may be made from the median ΔT2 in the 
ADC-delineated lesion. It is, however, important to recognise that T2 change following onset 
does not follow ‘one-line-fits-all’ kinetics (evidenced by the animal work), even for voxels in 
the same lesion within the same individual. As such, the scalar median ΔT2 also has different 
kinetics for different individuals, and there will be uncertainty in any onset time estimate made 
based on ΔT2 distributions due to inter-voxel and inter-individual heterogeneity. The 
uncertainty in onset time deriving from fitting a linear model across the entire cohort of rats 
was ±2.0 ms (rms), compared to ±5.7 ms in the cross-sectional human cohort. Therefore, ΔT2 
provides an onset time estimate but the inherent variation in T2 kinetics across individuals 
introduces greater uncertainty in humans than in rats. 
4.2. Limitations 
The current study has some limitations. First, the stroke lesions involved several vascular 
territories. It is impossible to conclude, from the current data set, whether T2 as a function of 
onset time is quantitatively uniform in different vascular territories. Second, the majority of 
patients in the current cohort (66%) were thrombolysed prior to MRI. However, ADC in the 
stroke lesions was not different between untreated and untreated patients indicating deep 
ischaemia in both cases. Busch et al. [1] showed in an embolic rat stroke model that in the 
core with severely lowered ADC rtPA does not influence perfusion, thus in the core rtPA is 
unlikely to accelerate vasogenic edema. In MCAo rat brain reperfusion leads to recovery of 
ADC T2, provided ischaemia is short-lasting [10]. We used the same ADC criteria for stroke 
lesions both in untreated and treated patient, thus in the light of the data above, T2 in the 
stroke tissue can be assumed to be unaffected by rtPA. Third, the use of T2-weighted signal 
intensity as reference for choosing voxels in the non-ischaemic hemisphere will inevitably 
become problematic with time as the time-dependent T2 increase will inevitably also affect 
T2-weighted signal. Careful inspection of Figure 5c indicates that in the scans acquired with 
the current parameters, T2 signal intensity shows a positive gradient with time in the ADC 
lesion beyond several hours. Elevated reference T2-weigthed signal intensity hours after the 
onset of stroke will diminish ΔT2, thereby underestimating onset time. In such cases, however, 
visual inspection of T2-weighted and quantitative T2 images may show elevated signal in the 
ADC lesion. One can reduce the sensitivity of T2-weighted signal to stroke by a suitable choice 
of TE and TR. Fourth, two types of MRI pulse sequences were used to quantify T2 in humans. 
These methods yield different absolute T2 from brain parenchyma. As explained in the Method 
section, the critical parameter used in determining the effects of stroke by both methods is 
T2, however. In the current data set it is impossible to separate T2s in ADC lesions 
measured by the two MRI methods. 
5. Conclusions 
We have shown, using a novel user-independent spherical reference method, that T2 
relaxation time increases as a function time from onset in human stroke lesion. The increase 
is approximately 1.9 ms/h which is comparable to that determined in a rat model of ischaemic 
stroke. We believe quantitative MRI exploiting T2 and ADC will have clinical impact in 
stratification of acute ischaemic stroke patients. 
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Table 1. Hyper-acute stroke patient data 
Variable  Hyper-Acute* 
Patients n = 38 
Female, n (%) 14 (37%) 
Study site, n (%)  
  Site 1 19 (50%) 
  Site 2 15 (39%) 
  Site 3 4 (11%) 
Median age, Y (IQR†) 68 (31 - 85) 
Received rtPA before MRI, n (%) 25 (66%) 
Median time from rtPA to MRI, hours:mins (IQR)  3:17 (2:09 – 4:30) 
Median time from onset to MRI, hours:mins (IQR)  4:21 (1:38 – 9:29) 
Median NIHSS‡ on admission,  (IQR) 6 (0 - 28) 
Stroke subtype§  
  Lacunar (LACS)  13 (37%) 
  Partial Anterior Circulation (PACS)  11 (31%) 
  Posterior Circulation (POCS) 3 (9%) 
  Total Anterior Circulation (TACS) 8 (23%) 
Left Hemisphere Stroke, n (%) 18 (51%) 
Median ADC Lesion Volume, cm3 (IQR) 1.35 (0.04 - 98.12)  
* MRI started within 9 hours of onset; † IQR is interquartile range; ‡ Scores on the National 
Institutes of Health Stroke Scale (NIHSS) range from 0 to 42, with higher scores indicating 
greater deficit; § Strokes classified according to the Oxford Stroke Classification Scale. 
 
 
Table 2. MRI sequence details and acquisition parameters. 
Site 
T2 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] 
  
Bristol GRASE 3000 20, 40, 60, 80, 100 0.6×0.6×2.3   
Glasgow TSE 12500 9.5, 66, 123 1.7×1.7×2.0   
Oxford FSE 12000 7.7, 77, 177 1.7×1.7×2.2   
Site 
T1 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] TI [ms] Flip Angle 
Bristol 3D FFE 6.84 3.18 1.0×1.0×1.1 N/A 8° 
Glasgow MP-RAGE 2200 2.28 0.9×0.9×0.9 900 9° 
Oxford MP-RAGE 2040 4.55 1.8×1.8×1.0 900 8o 
Site 
Diffusion 
Sequence 
TR 
[ms] TE [ms] 
Resolution 
[mm3] 
b-value [s/mm2] 
(Multiplicity) 
Independent 
Gradient 
Directions 
Bristol SE-EPI 3009 60.5 1.2×1.2×4.4 0 (1), 1000 (3) 3 
Glasgow SE-EPI 8000 90 0.9×0.9×2.0 0 (3), 1000 (20) 20 
Oxford SE-EPI 9000 98 1.8×1.8×2.6 0 (1), 1000 (1) 1 
 
 
 
 
LEGENDS TO THE FIGURES 
 
Figure 1: Illustration of the spherical reference method for estimating change due to stroke.  
Panel (a) shows a T2-weighted (echo-summed) image from an ADC-negative patient, used 
here to demonstrate the process applied to ADC-positive patients. The highlighted voxel 
(green) on the left represents a voxel within a lesion for which an estimate for the pre-
ischaemic T2 is required. The red circle (a slice through a sphere) is the reference sphere 
from which voxels are selected that match the intensity of the ‘lesion’ voxel. Here, for clarity, 
the radius of the reference sphere is exaggerated and is usually 2 – 10 mm. Panel (b) shows 
the normalised intensity difference, (𝐼𝐿 − 𝐼𝑘) 𝐼
𝐿⁄ , where 𝐼𝐿 is the T2-weighted intensity of the 
lesion voxel (green), and 𝐼𝑘 is the intensity of the kth voxel within the reference sphere. Panel 
(c) shows the penalty function with 𝜎 = 0.1, a typical value. Panel (d) shows quantitative T2 
values [ms] within the reference sphere. Panel (e) shows a voxel-wise multiplication of the 
penalty function with the T2 values within the reference sphere. An estimate for the pre-
ischaemic T2 is then obtained by summing the voxel values from the images of panels (c) and 
(e) and normalising the latter by the former. 
 
 Figure 2: Images of ADC and T2 calculated by the voxel-wise parameter change algorithm 
in a MCAo rat.  
ADC (a and b) and T2 (e and f) were acquired at 1 and 4 hours, respectively, from a typical 
MCAo rat. Panels (c) and (d) are colour-coded ADC images for panels (a) and (b) with values 
given by vertical reference bars. Panels (g) and (h) are colour-coded T2 images for panels (e) 
and (f), respectively, with vertical reference bars in ms. 
 Figure 3: Change of T2 distributions in stroke lesions with time in MCAo rats, calculated 
using the voxel-wise algorithm.  
Panel (a) shows histograms of the lesion T2 distribution at 1, 2, 3, and 4 hours post-occlusion. 
Panel (b) shows the time course of the median T2 (uncertainties are represented by median 
absolute deviations of the T2 distribution) in a set of rats. 
 
Figure 4: Estimates of change in quantitative imaging parameters due to acute ischaemic 
stroke in a patient.  
Panel (a) shows an ADC map, with a lesion visible in the right (image left) hemisphere. Panel 
(b) shows the estimated change in ADC from the pre-ischaemic state. Panel (c) shows a T2 
map, panel (d) shows the estimated T2 change from the pre-ischaemic state. Panels (e – f) 
show ΔT2 distributions: Panel (e) shows the distribution for the normal tissue in hemisphere 
of the lesion, and panel (f) the distribution in an acute ischaemic stroke lesion. 
 Figure 5: Quantitative relationships between T2 and stroke onset time in human patients. 
Panel (a) shows the median ΔT2 (mad with error bars) in the ADC-demarcated lesions against 
stroke onset time using the spherical reference method. r2 = 0.319, p-value = 0.000222. Panel 
(b) shows the difference in median T2 between the lesion and its mirrored contralateral region 
against onset time, r2 = 0.139, p-value = 0.0213. Panel (c) shows T2-weighted signal 
difference vs time, the slope of the graph is not significantly different to zero. 
 Figure 6: ROCs for the spherical (red line) and mirror reference (black line) approaches for 
identifying scans performed within 4.5 hours of symptom onset.  
 
